Alfaro, Merlyn D.
HRN: 01-24-35 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/24/2026
CEFTRIAXONE 1G (VIAL)
05/24/2026
05/30/2026
IV
2g
OD
CAP MR
Checking Initial Appropriateness
05/25/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/25/2026
06/02/2026
IV
2.25g
Q8
CAP HR
Checking Initial Appropriateness
05/31/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/31/2026
06/07/2026
IV
2.25 + . 75g ( On HD Days)
Q8
CAP HR
Checking Initial Appropriateness
06/09/2026
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
06/09/2026
06/15/2026
TOPICAL
25g
BID
Sacral Ulcer
Checking Initial Appropriateness